{"product_id":"lucires-resmetirom","title":"LuciRes (Resmetirom)","description":"\u003ch2\u003eAbout Resmetirom\u003c\/h2\u003e\u003cp\u003eResmetirom is a medication used for the treatment of noncirrhotic nonalcoholic steatohepatitis.\u003csup id=\"cite_ref-Rezdiffra_FDA_label_1-1\" class=\"reference\"\u003e\u003c\/sup\u003e It is a thyroid hormone receptor beta (NR1A2) agonist.\u003c\/p\u003e\u003ch3\u003eNonalcoholic Steatohepatitis\u003c\/h3\u003e\u003cp\u003eIndicated in conjunction with diet and exercise for treatment of adults with noncirrhotic nonalcoholic steatohepatitis (NASH) with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis)\u003c\/p\u003e\u003cp\u003eDosage is based on actual body weight\u003c\/p\u003e\u003cp\u003e\u0026lt;100 kg: 80 mg PO qDay\u003c\/p\u003e\u003cp\u003e≥100 kg: 100 mg PO qDay\u003c\/p\u003e\u003ch3\u003eDosage Modifications\u003c\/h3\u003e\u003ch4\u003eDosage modifications for CYP2C8 inhibitors\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eStrong CYP2C8 inhibitors (eg, gemfibrozil): Not recommended\u003c\/li\u003e\n\u003cli\u003e\n\u003ch5\u003eModerate CYP2C8 inhibitors (eg, clopidogrel)\u003c\/h5\u003e\n\u003cul\u003e\n\u003cli\u003e\u0026lt;100 kg: Reduce to 60 mg PO qDay\u003c\/li\u003e\n\u003cli\u003e≥100 kg: Reduce to 80 mg PO qDay\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003eRenal impairment\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eMild or moderate (CrCl ≥30 mL\/min): No dosage adjustment necessary\u003c\/li\u003e\n\u003cli\u003eSevere (CrCl \u0026lt;30 mL\/min): Not studied\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch4\u003eHepatic impairment\u003c\/h4\u003e\u003cul\u003e\n\u003cli\u003eMild (Child-Pugh A): No dosage adjustment necessary\u003c\/li\u003e\n\u003cli\u003eModerate or severe (Child-Pugh B or C): May increase resmetirom plasma concentrations and risk of resmetirom adverse reactions\u003c\/li\u003e\n\u003cli\u003eDecompensated cirrhosis (consistent with moderate to severe hepatic impairment): Avoid use\u003c\/li\u003e\n\u003cli\u003eNASH cirrhosis: Safety and efficacy not established\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eDosing Considerations\u003c\/h3\u003e\u003cp\u003eLimitation of use: Avoid use in patients with decompensated cirrhosis\u003c\/p\u003e","brand":"Lucius Pharmaceuticals (Lao) Co., Ltd","offers":[{"title":"Default Title","offer_id":44797955899435,"sku":"RL202501s250s300s380","price":0.0,"currency_code":"AMD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0701\/3528\/3755\/files\/2024-12-1267.jpg?v=1787022244","url":"https:\/\/xomeds.com\/products\/lucires-resmetirom","provider":"XOMEDS","version":"1.0","type":"link"}